Author:
Zhao Lixia,Liu Shuai,Peng Yanqiu,Zhang Jian
Funder
National Natural Science Foundation of China
Guizhou Provincial Science and Technology Program
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Johnson, J. et al. From mesenchymal stromal cells to engineered extracellular vesicles: A new therapeutic paradigm. Front. Cell Dev. Biol. 9, 705676 (2021).
2. Chen, Q. et al. Fate decision of mesenchymal stem cells: Adipocytes or osteoblasts?. Cell Death Differ. 23(7), 1128–1139 (2016).
3. Jain, M. et al. Amniotic fluid mesenchymal stromal cells derived from fetuses with isolated cardiac defects exhibit decreased proliferation and cardiomyogenic potential. Biology 12(4), 552 (2023).
4. Biswas, A. et al. Human placenta/umbilical cord derivatives in regenerative medicine—Prospects and challenges. Biomater. Sci. 11(14), 4789–4821 (2023).
5. Liebig, B. E. et al. The platelet-rich plasma and mesenchymal stem cell milieu: A review of therapeutic effects on bone healing. J. Orthop. Res. 38(12), 2539–2550 (2020).